NS2214: Began Phase I trial in the U.K.

NeuroSearch A/S, Copenhagen Product: NS2214, relieves symptoms of Parkinson's disease without producing dyskinesia (uncontrolled movements) Indication: Parkinson's disease Status: Began Phase I trial ...